244 related articles for article (PubMed ID: 30808829)
1. Serum miR-192 Is Related to Tubulointerstitial Lesion and Short-Term Disease Progression in IgA Nephropathy.
Fan Q; Lu R; Zhu M; Yan Y; Guo X; Qian Y; Zhang L; Dai H; Ni Z; Gu L
Nephron; 2019; 142(3):195-207. PubMed ID: 30808829
[TBL] [Abstract][Full Text] [Related]
2. Intrarenal expression of microRNAs in patients with IgA nephropathy.
Wang G; Kwan BC; Lai FM; Choi PC; Chow KM; Li PK; Szeto CC
Lab Invest; 2010 Jan; 90(1):98-103. PubMed ID: 19901913
[TBL] [Abstract][Full Text] [Related]
3. Blood TGF-β1 and miRNA-21-5p levels predict renal fibrosis and outcome in IgA nephropathy.
Bharti N; Agrawal V; Kamthan S; Prasad N; Agarwal V
Int Urol Nephrol; 2023 Jun; 55(6):1557-1564. PubMed ID: 36648741
[TBL] [Abstract][Full Text] [Related]
4. CD147 renal expression as a biomarker for progressive IgAN.
Sun S; Zhao A; Li R; Du R; He L; Sun W; Wang H; Huang C
J Nephrol; 2015 Jun; 28(3):307-14. PubMed ID: 25510296
[TBL] [Abstract][Full Text] [Related]
5. C5b-9 glomerular deposition and tubular alpha3beta1-integrin expression are implicated in the development of chronic lesions and predict renal function outcome in immunoglobulin A nephropathy.
Stangou M; Alexopoulos E; Pantzaki A; Leonstini M; Memmos D
Scand J Urol Nephrol; 2008; 42(4):373-80. PubMed ID: 19230171
[TBL] [Abstract][Full Text] [Related]
6. Urinary exosomal miRNA-451a can be used as a potential noninvasive biomarker for diagnosis, reflecting tubulointerstitial damage and therapeutic response in IgA nephropathy.
Zhang Q; Zhao Y; Luo Y; Guo S; Hou H; Han X; Zhou Y
Ren Fail; 2024 Dec; 46(1):2319326. PubMed ID: 38379319
[TBL] [Abstract][Full Text] [Related]
7. Urinary miR-185-5p is a biomarker of renal tubulointerstitial fibrosis in IgA nephropathy.
Duan ZY; Bu R; Liang S; Chen XZ; Zhang C; Zhang QY; Li JJ; Chen XM; Cai GY
Front Immunol; 2024; 15():1326026. PubMed ID: 38426107
[TBL] [Abstract][Full Text] [Related]
8. Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis.
Del Prete D; Gambaro G; Lupo A; Anglani F; Brezzi B; Magistroni R; Graziotto R; Furci L; Modena F; Bernich P; Albertazzi A; D'Angelo A; Maschio G
Kidney Int; 2003 Jul; 64(1):149-59. PubMed ID: 12787405
[TBL] [Abstract][Full Text] [Related]
9. Steroid therapy and urinary transforming growth factor-beta1 in IgA nephropathy.
Haramaki R; Tamaki K; Fujisawa M; Ikedo H; Haramaki N; Okuda S
Am J Kidney Dis; 2001 Dec; 38(6):1191-8. PubMed ID: 11728950
[TBL] [Abstract][Full Text] [Related]
10. Non-Proximal Renal Tubule-Derived Urinary Exosomal miR-200b as a Biomarker of Renal Fibrosis.
Yu Y; Bai F; Qin N; Liu W; Sun Q; Zhou Y; Yang J
Nephron; 2018; 139(3):269-282. PubMed ID: 29539618
[TBL] [Abstract][Full Text] [Related]
11. Relationship between blood neutrophil-lymphocyte ratio and renal tubular atrophy/interstitial fibrosis in IgA nephropathy patients.
Chai L; Cai K; Wang K; Luo Q
J Clin Lab Anal; 2021 Jun; 35(6):e23774. PubMed ID: 33951240
[TBL] [Abstract][Full Text] [Related]
12. Role of tubulointerstitial plasmin in the progression of IgA nephropathy.
Uchida T; Oda T; Takechi H; Matsubara H; Watanabe A; Yamamoto K; Oshima N; Sakurai Y; Kono T; Shimazaki H; Tamai S; Kumagai H
J Nephrol; 2016 Feb; 29(1):53-62. PubMed ID: 25971850
[TBL] [Abstract][Full Text] [Related]
13. Urinary sediment miRNAs reflect tubulointerstitial damage and therapeutic response in IgA nephropathy.
Liang S; Cai GY; Duan ZY; Liu SW; Wu J; Lv Y; Hou K; Li ZX; Zhang XG; Chen XM
BMC Nephrol; 2017 Feb; 18(1):63. PubMed ID: 28201996
[TBL] [Abstract][Full Text] [Related]
14. Roles of TGF-beta1 and apoptosis in the progression of glomerulosclerosis in human IgA nephropathy.
Chihara Y; Ono H; Ishimitsu T; Ono Y; Ishikawa K; Rakugi H; Ogihara T; Matsuoka H
Clin Nephrol; 2006 Jun; 65(6):385-92. PubMed ID: 16792132
[TBL] [Abstract][Full Text] [Related]
15. Circulating TNF receptors 1 and 2 are associated with the severity of renal interstitial fibrosis in IgA nephropathy.
Sonoda Y; Gohda T; Suzuki Y; Omote K; Ishizaka M; Matsuoka J; Tomino Y
PLoS One; 2015; 10(4):e0122212. PubMed ID: 25860248
[TBL] [Abstract][Full Text] [Related]
16. Localization of transforming growth factors beta1 and beta2 and epidermal growth factor in IgA nephropathy.
Taniguchi Y; Yorioka N; Masaki T; Asakimori Y; Yamashita K; Yamakido M
Scand J Urol Nephrol; 1999 Aug; 33(4):243-7. PubMed ID: 10515087
[TBL] [Abstract][Full Text] [Related]
17. Neuroblastoma suppressor of tumorigenicity 1 is associated with the severity of interstitial fibrosis and kidney function decline in IgA nephropathy.
Kobayashi H; Satake E; Murata Y; Otsuka H; Tsunemi A; Azuma M; Nakamura Y; Saito T; Abe M
J Nephrol; 2023 Nov; 36(8):2245-2256. PubMed ID: 37436574
[TBL] [Abstract][Full Text] [Related]
18. Tubular and interstitial expression of ICAM-1 as a marker of renal injury in IgA nephropathy.
Arrizabalaga P; Solé M; Abellana R; de las Cuevas X; Soler J; Pascual J; Ascaso C
Am J Nephrol; 2003; 23(3):121-8. PubMed ID: 12566693
[TBL] [Abstract][Full Text] [Related]
19. CD44 expression in IgA nephropathy.
Florquin S; Nunziata R; Claessen N; van den Berg FM; Pals ST; Weening JJ
Am J Kidney Dis; 2002 Feb; 39(2):407-14. PubMed ID: 11840384
[TBL] [Abstract][Full Text] [Related]
20. Association of URG11 and Twist with clinical pathological characteristics and prognosis in patients with IgA nephropathy.
Du R; Zhao L; Xia L; Liu L; Sun W; Zhao A; Yu Y; Han H; Sun S
Nephrol Dial Transplant; 2013 Sep; 28(9):2268-76. PubMed ID: 23828164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
